
BRYZAI Advisory
Tailored thinking. Focused solutions.
We start with your decision, not the data. Together we find the uncertainty that really matters, work out what evidence would settle it, and design the optimal study or analysis to get you there.
BRYZAI Advisory is a founder-led consultancy drawing on nearly 40 years of combined quantitative expertise, including nearly 10 years at GSK and Bayer and director-level consulting supporting Sanofi.
Our experience spans Phase II to post-marketing across multiple therapeutic areas, combining clinical trial design, advanced statistical methodology, digital measurement and evidence strategy.
Explore Advisory
